Effect of the sugar chain of soluble recombinant CD59 on complement inhibitory activity
Open Access
- 2 December 1996
- journal article
- Published by Wiley in FEBS Letters
- Vol. 399 (3) , 272-276
- https://doi.org/10.1016/s0014-5793(96)01340-3
Abstract
A soluble recombinant CD59#77 (rCD59#77), consisting of 77 amino acids starting from the N terminus of membrane‐bound CD59, was prepared using a gene expression system in CHO cells. The rCD59#77 preparation was composed of glycosylated and non‐glycosylated forms (G and NG forms). Unexpectedly, NG form was 7 times more potent than G form in complement inhibitory activity. Postulating that sialic acids on G‐form molecules make it difficult for rCD59#77 to access nascent membrane attack complexes on the cell surface, the sialic acids were removed by neuraminidase treatment. However, the inhibitory activity was not changed. Next, one of two putative N‐glycosylation sites was mutated by substituting Gln18 for Asn18. The mutant, designated rCD59#77(N/Q), had no sugar moiety and was as active as the NG form of rCD59#77. These results suggest that the bulky sugar moiety at Asn18 is not necessary for the complement‐inhibitory activity of rCD59 and actually hampers that function.Keywords
This publication has 25 references indexed in Scilit:
- Activation of the terminal complement cascade in renal infarctionKidney International, 1995
- Determination of the active site of CD59 with synthetic peptidesMolecular Immunology, 1995
- Physiology and Pathophysiology of Complement: Progress and TrendsCritical Reviews in Clinical Laboratory Sciences, 1995
- Role of CD59 in experimental glomerulonephritis in ratsKidney International, 1994
- Structure of a soluble, glycosylated form of the human complement regulatory protein CD59Structure, 1994
- CD59 expressed by human endothelial cells functions as a protective molecule against complement‐mediated lysisEuropean Journal of Immunology, 1992
- The control of homologous lysisImmunology Today, 1991
- Glycosylation of the human erythrocyte glucose transporter is essential for glucose transport activityBiochimica et Biophysica Acta (BBA) - Biomembranes, 1990
- N-Deglycosylation of human complement component C9 reduces its hemolytic activityMolecular Immunology, 1989
- Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria.Journal of Clinical Investigation, 1989